John Hussman's ELV Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 4,200 shares of Elevance Health, Inc. (ELV) worth $1.63 M, representing 0.35% of the portfolio. First purchased in 2014-Q4, this short-term holding has been held for 7 quarters.
Based on 13F filings, John Hussman has maintained this position in ELV for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2026, adding 4,200 shares. Largest reduction occurred in Q3 2015, reducing 50,000 shares.
Analysis based on 13F filings available since 2013 Q2
John Hussman's Elevance Health (ELV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Elevance Health (ELV) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +4,200 | New Buy | 4,200 | $388.82 |
| Q1 2025 | -2,100 | Sold Out | 0 | $0.00 |
| Q4 2024 | +2,100 | New Buy | 2,100 | $368.90 |
| Q3 2015 | -50,000 | Sold Out | 0 | $0.00 |
| Q4 2014 | +50,000 | New Buy | 50,000 | $125.68 |
John Hussman's Elevance Health Investment FAQs
John Hussman first purchased Elevance Health, Inc. (ELV) in Q4 2014, acquiring 50,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held Elevance Health, Inc. (ELV) for 7 quarters since Q4 2014.
John Hussman's largest addition to Elevance Health, Inc. (ELV) was in Q4 2014, adding 50,000 shares worth $6.28 M.
According to the latest 13F filing for Q3 2026, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 4,200 shares of Elevance Health, Inc. (ELV), valued at approximately $1.63 M.
As of the Q3 2026 filing, Elevance Health, Inc. (ELV) represents approximately 0.35% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in Elevance Health, Inc. (ELV) was 50,000 shares, as reported at the end of Q4 2014.